Friday, July 31, 2026

One Line of Text Can Trick This AI Into Stealing Crypto, Researchers Warn

Researchers reveal AI vulnerabilities in cryptocurrency transactions, allowing manipulation of chatbots to facilitate theft.

Robots, English, and AI—North Korea’s Schools Suddenly Sound Like Silicon Valley

North Korea's education system is evolving with new teaching methods, early foreign language education, and a focus on critical thinking skills.

Who is the Mystery Man? BLACKPINK’s Jennie Sparks Curiosity with New Photo

BLACKPINK's Jennie shares a mysterious photo with an unidentified man, sparking fan theories about its significance and a possible music release.

Tag: trial

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

MetaVia to Present DA-1726 Phase 1 Obesity Trial Data at EASL Congress 2026

Dong-A ST's Meta via will present DA-1726, a dual-action obesity treatment, at the EASL Congress 2026, showcasing promising clinical trial results.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

A New Study Suggests Selenium Could Help With One of Chemotherapy’s Most Disruptive Side Effects

A study reveals high-dose selenium can reduce exercise-related dysfunction in ovarian cancer patients undergoing chemotherapy.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

A Long-Acting Oral Drug? Yuhan’s Latest Trial Update Is Turning Heads

Yuhan Corp's YH35995 shows promising results for Gaucher disease in Phase 1 trial, demonstrating long-lasting efficacy and BBB penetration.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Revolutionary TNZ Alloy Implants: 4x Stronger Than Titanium for Better Dental Health

Korean researchers have developed a next-gen implant alloy that outperforms titanium, mimicking bone properties and ensuring higher strength.

Unlock Healthier Hair: JW Shinyak’s Ducray Neoptide Expert Shows 93.6% User Satisfaction in Global Study

JW Shinyak's Ducray Neoptide Expert shows significant hair improvement in a global trial, with high user satisfaction across ages and conditions.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

First Patient Registered in Vietnam: A Milestone for Dengue Treatment Trials by Hyundai BioScience

Hyundai Bio Science has registered its first patient for a dengue treatment trial in Vietnam, marking a significant milestone.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.